The Bioavailability Problem
Polyphenols — the flavonoids, phenolic acids, stilbenes, and tannins found in fruits, vegetables, tea, coffee, wine, and cocoa — are among the most consumed bioactive compounds in the human diet. Epidemiological studies consistently associate high polyphenol intake with reduced cardiovascular risk, lower cancer incidence, and improved metabolic health. Yet most dietary polyphenols have extremely poor bioavailability: only 5 to 10 percent are absorbed in the small intestine. The remaining 90 to 95 percent pass to the colon intact.
The Microbial Transformation
In the colon, gut bacteria metabolise polyphenols into smaller, more bioavailable compounds. Ellagitannins (from pomegranates, walnuts, berries) are converted into urolithins — metabolites with anti-inflammatory, anti-cancer, and mitochondria-enhancing properties. Isoflavones (from soy) are converted into equol — an oestrogen-receptor modulator with cardiovascular and bone-health implications. Flavanones (from citrus) are deglycosylated and ring-fissioned by bacterial enzymes into phenolic acids that are absorbed from the colon.
The Responder Problem
Not everyone benefits equally from polyphenol consumption, because not everyone has the bacteria needed for conversion. Only 25 to 50 percent of the Western population produces equol from soy isoflavones — "equol producers" harbour Adlercreutzia equolifaciens and related bacteria, while "non-producers" lack these species. Similarly, urolithin production from ellagitannins depends on specific colonic bacterial consortia, and "metabotype" classification (urolithin A producers vs B producers vs non-producers) predicts differential health benefits from pomegranate consumption.
Bidirectional Effects
The relationship between polyphenols and the microbiome is bidirectional. Polyphenols act as selective growth substrates and antimicrobial agents, reshaping community composition. Green tea catechins and red wine proanthocyanidins increase Bifidobacterium and Lactobacillus abundance while suppressing pathogenic taxa. Cocoa flavanols increase Bifidobacterium and Lactobacillus within 4 weeks of regular consumption. These prebiotic-like effects mean that polyphenol-rich diets support the very bacteria needed for polyphenol metabolism — a positive feedback loop.
Practical Implications
The polyphenol-microbiome interaction reinforces two principles. First, the health benefits of plant-rich diets are partly microbiome-mediated — providing another mechanistic argument for dietary diversity. Second, individual responses to "superfoods" vary based on microbiome composition — which may explain why some people experience dramatic benefits from specific foods while others notice nothing. The solution is not personalised polyphenol supplementation (which is premature) but consistent, diverse plant consumption that builds and maintains the bacterial communities needed for polyphenol activation.